CCI 10.2: Look out for new Lidocaine edits

Why This Topic Matters

The update matters because it changes whether certain services may be reported separately or are now bundled under Medicare claims edits. Practices that work in interventional pain, neurology, anesthesia, or infusion-related services may need to review their coding workflows and payer policies.

Article Sections

1. CCI 10.2 Overview

   Introduces the Version 10.2 Medicare CCI update and summarizes the general areas affected by the new edits. Provides context for the article’s discussion of pain-management and procedure-billing changes.

2. Lidocaine and surgical procedure edits

   Discusses changes involving topical analgesia and IV lidocaine-related billing in relation to a broad group of surgical procedures. Notes the relevance of Medicare claims processing edits and related bundling changes.

3. Nerve test edits with spinal injections and nerve blocks

   Covers new bundling edits affecting diagnostic nerve testing when performed with selected pain procedures. Includes discussion of how these edits intersect with electromyography use in clinical practice.

4. Other 10.2 CCI edits

   Summarizes additional updates involving fluoroscopic guidance and chemotherapy infusion-related billing. Also notes related pump refill and catheter procedure topics.